For Oncologists - The Founding Panel

Join the founding panel of the first navigation intelligence layer for oncology.

We are assembling a TMH-alumni-led founding panel across 11 disease management groups. Cases are AI-prepared and sub-specialty-matched. Workflow respects your time. Compensation is fair and paid in 7 days. The opinion you write is your own - fully independent.

11
Disease Management Groups
50
Founding Specialist Cap
48 h
Standard Opinion Turnaround
7 days
Payment Cycle

Why this, why now

A structured second-opinion layer for global oncology. Built by clinicians.

Cancer cases today reach senior oncologists fragmented - records across three centres, biomarkers buried in long PDFs, treatment chronologies that exist only in the patient's memory. By the time the case reaches a sub-specialist, much of the consultation is record-reading, not decision-making. And the patient often arrives at the wrong sub-specialty for their actual case.

The Brown Sage is a navigation intelligence layer - what we call Cancer Care GPS. We structure the case before it reaches you. We route by clinical relevance, not by who is online. We pay fairly and on time. And we do not take referral commissions - ever.

For too long, the cost of fragmented intake has been borne silently by the consulting oncologist. That is the problem we are built to remove from your workflow.

The founding panel is being assembled deliberately - small, peer-led, and TMH-anchored. The first 50 active Founding Specialists will shape how the platform routes, scores, and reviews cases for the decade ahead.

The architecture

Three intelligence layers.

Each layer does one thing well. L1 reads. L2 routes. L3 knows. The compounding is where the real intelligence lives.

L1Clinical Intelligence

The layer that reads the case. Fragmented records - scans, path, prescriptions, prior opinions - are organised into a structured clinical view a sub-specialist can act on in four minutes.

  • 200+ structured data points extracted per case
  • 70+ biomarkers verified (ER, PR, HER2, PD-L1, EGFR, BRCA, MSI, MMR, ALK, ROS1, NTRK, more)
  • Cross-checked against NCG, ICMR, ACS, NCI-PDQ, and Africa-specific guidelines
  • 100+ drug-name validation dictionary with OCR correction
  • Output in FHIR R4 / LOINC interoperable format
  • Clinician verification on every value before the case reaches you
L2Matchmaking Intelligence

The layer that routes the case. Clinical-relevance routing - by DMG, stage, biomarker profile, treatment history, complexity, and your declared sub-specialty focus. Not by queue order. Not by geography.

  • Multi-factor routing across cancer type, stage, and biomarker
  • Treatment history and complexity weighted into match
  • Your declared DMG and sub-specialty focus respected
  • Patient sees match score & reasoning - final selection is theirs
  • Your case-volume ceiling and availability honoured automatically
  • No case reaches you outside your declared sub-specialty
L3Knowledge Layer

The layer behind both. Every case L1 structures is scored for concordance against National Cancer Grid (India's Tata Memorial-led standard), ICMR, and NCCN guidelines. The patient sees whether their current treatment plan aligns with what India's top cancer centres recommend for their exact profile. Output is FHIR-interoperable - any hospital EMR or tumour board system can consume it directly.

  • Guideline concordance scoring - NCG (India), ICMR, and NCCN
  • Patient sees how their plan compares to published standards for their exact stage and profile
  • NCI PDQ + MedlinePlus + PMC knowledge base in pgvector
  • FHIR R4 interoperable output - hospital EMR and tumour board systems can consume directly
  • Full DPDPA 2023 compliance - no identifiable patient data in the knowledge layer
  • Clinical trial matching available on request

Your workflow

Four steps. Built around your time.

From routed case to written opinion. The lengthy record review you do today is largely done before the case reaches you. The time you save goes back into the decision itself.

01
When a case arrives
Routed to you

A case lands in your queue only when DMG, stage, biomarker, treatment history, and your declared sub-specialty focus all align. You see the case context, the matchmaking rationale, and the patient's prepared questions before you begin.

02
Reading time - minutes
Read the structured view

The case arrives as a structured clinical view - diagnosis, stage, pathology, biomarkers, chronology, active flags, pending workup, patient's questions. Every value is traceable to its source. Full source documents available on tap.

03
In your own format
Write your opinion

A single free-text window. No fixed template. You write the opinion in the format you are most comfortable with - your judgement, your voice. Submit when ready.

04
Within 7 days
Paid into your account

Transferred directly within 7 days of opinion delivery - at the pre-agreed per-case fee. You receive the full amount; no deductions at our end. Clean, simple, on time.

Compliance & protections

Built around the standards. No shortcuts.

Every part of the platform is designed around India's DPDPA 2023 and the NMC Telemedicine Practice Guidelines 2020 - alongside the data-protection standards of every region we serve.

Data protection

DPDPA 2023 compliant.

Patient records are encrypted in transit (TLS 1.3) and at rest (AES-256). Patient consent captured before any record reaches a specialist. Per-case audit trail. The right to withdraw consent is built into the platform. Breach notification protocols in place.

Clinical practice

NMC Telemedicine Guidelines 2020.

Your NMC registration number displayed on every opinion you issue. Records retained for 3 years per regulation. Scope of opinion clearly stated. Patient told that the opinion is for consultation with their primary treating clinician - not a replacement for it.

Liability framework

Standard global second-opinion model.

You provide a written second opinion based on documented records - not primary care, not a doctor-patient relationship in the full clinical sense. The same liability framework used internationally by 2nd.MD, Cleveland Clinic, and MORE Health, and in India by Navya. The full framework document is available to review at the point of empanelment.

A look at the workflow

Watch the 3-minute walkthrough.

A real case, end to end. From a patient's uploaded records, through the Clinical Intelligence and Matchmaking layers, to the structured view that arrives in a specialist's queue.

Most of the questions a 15-minute call would answer are answered here. If you have time for one thing on this page, watch this.

Duration3 minutes
FormatScreen walkthrough - real case
Best forBefore the first call
VIDEO EMBED - TBS WALKTHROUGH
Replace with iframe when ready

Common questions

The questions most often asked.

Tap any question to read the answer. Anything we have not addressed here can be raised directly with Dr Pritesh in your first call.

01Does The Brown Sage handle only cancer cases?+
Yes. The Brown Sage is exclusively an oncology platform. Every case routed through us is a cancer case - we do not accept, process, or route any non-oncology referrals. This focus is deliberate: it allows us to build deep, cancer-specific clinical intelligence (extraction, staging, biomarker structuring, guideline matching) that a general-purpose platform cannot match. Our AI pipeline, our specialist panel, our matchmaking, and our quality gates are all designed around oncology workflows. If a non-cancer case is submitted by mistake, it is flagged and returned at intake - it never reaches the specialist panel.
02What is the legal liability framework? Am I exposed if my opinion is later contested?+
You are providing a written second opinion based on documented records - not assuming primary care, and not establishing a doctor-patient relationship in the full clinical sense. This is the global standard liability framework used internationally and by Navya in India. Every opinion you issue carries (a) your NMC registration number, (b) explicit scope language stating it is a remote written opinion based on the records provided, (c) a clear recommendation that the patient consult their primary treating clinician for treatment decisions. Patient consent is captured before any record reaches you. The full framework document is available to review at the point of empanelment.
03How do you ensure I won't receive cases outside my actual sub-specialty?+
This is exactly what the Matchmaking Intelligence layer (L2) does. During onboarding, you select your DMGs (multi-select) and your top three sub-specialty focus areas within each DMG (e.g., within Breast - HER2+, TNBC, oncoplastic). You declare the case types you'll receive (Early Stage / Locally Advanced / Oligometastatic / Metastatic / Residual or Recurrent). Cases route to you only when DMG, sub-specialty focus, case type, and your availability all align. If a case does not match cleanly, it does not reach you. You may also decline any individual case without explanation - no penalty.
04How is patient data secured? What happens if there's a breach?+
All patient data is encrypted in transit (TLS 1.3) and at rest (AES-256). Access is role-based, audit-logged, and revocable. Your access is limited to the specific cases routed to you, and ceases when an opinion is delivered. We are fully compliant with India's Digital Personal Data Protection Act, 2023 - including patient consent capture before any record reaches the specialist, the right to withdraw consent, and breach notification protocols. We do not retain patient identity beyond the period mandated by the NMC Telemedicine Guidelines. We carry cyber-liability insurance for the platform. In the event of a platform-side breach, the specialist who reviewed the case is not personally exposed.
05What is the realistic case volume? I don't want to be a "dormant" specialist.+
Honest answer - case volume in the first 3 months will be lower than at steady state, because the patient-acquisition engine ramps in parallel with specialist onboarding. We are deliberately capping the founding cohort at ~50 active specialists across 11 DMGs precisely to avoid the marketplace death-spiral of "too many specialists, not enough cases." Realistic targets: 2-3 cases per month in Quarter 1, 4-6 cases per month by Quarter 2, 6-10 cases per month at steady state from Quarter 3 onwards. The minimum 3-per-quarter floor exists to maintain active status; if we fail to route those cases to you, no penalty.
06What happens if a patient disputes my opinion or asks for a refund?+
If a patient is dissatisfied with the clinical opinion (rather than process issues like delivery or communication), we offer them the option of a second review by a different specialist at no additional cost to them. The original specialist is paid in full regardless. If a patient raises a serious concern about clinical quality, the matter is reviewed by Dr Pritesh and an external clinical advisor. The platform absorbs the cost of process-related refunds (delayed delivery, technical issues); specialists are never out of pocket for platform failures.
07What if I decide this isn't for me? Is there a notice period or exit penalty?+
You may exit the panel at any time, with no penalty and no notice period beyond completing any cases currently in your queue (maximum 1-2 cases at any given moment, given our matchmaking model). Exit is handled through your dashboard - no paperwork required. Your right to revoke patient-record access is built into the platform. Any earnings owed to you at the time of exit are paid out on the next 7-day cycle. We expect that some founding specialists will discover the workflow isn't a fit - and we'd rather know within 90 days than lose your trust by trying to retain you against your preference. The exit door is always available; we just intend that you won't want to use it.

If this resonates, write to Pritesh.

If the walkthrough has covered what you needed to see, the next step is the empanelment form and the pre-agreed compensation. A 15-minute call follows only if you'd like one.

Dr Pritesh Shah
Dr Pritesh Shah
Founder & CEO
drpritesh@thebrownsage.com
+91 97734 58283
MD Radiodiagnosis (TMH) - CPHM (ISB) - EPHM (IIM)